@AdamRochussen Why Ed did not ask for corresponding author for that Nat neuroscience paper? If Ed is first author and corresponding author, things will be different.
NIH proposes to report peer review outcomes as falling into one of three categories: Most Competitive, Competitive, Not Discussed.
Overall impact scores will no longer be reported to either the applicants or program officers.
Exciting to see stem cell therapies moving closer to clinical reality. I was pleased to share my perspective with Nature on recent advances in stem cell–based treatments for type 1 diabetes and other autoimmune diseases.
https://t.co/8j80AAUNkw
Here is the "effective payline" for each institute, estimated (by Claude) as the percentile where one can expect 80% probability of funding from a logistic regression fit. The effective payline has gone from a historic ~12% to 6% in 2025.
The Lian lab published a new paper titled: Ultrasound Control of Gene Expression in Human iPSCs via Heat Shock Promoters. Here is the paper link: https://t.co/EwBOk7dK9O
We have developed a new method MAGIK for robust gene knockin in hPSCs. We showed MAGIK can be utilized to insert fluorescent proteins into various genes, including SOX17, NKX6.1, NKX2.5, and PDX1, across multiple hPSC lines.
https://t.co/q1yIG7AtXJ
the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
We temporarily activated the targeted genes, enabling live cell sorting of the correctly knockin cells. In this way, we eliminate the need of screening hundreds of single cell derived clones to identify targeted cells.
In our new paper, we used iCas9 and a dCas9 activator modRNA to substantially enhance gene knockin efficiency in human stem cells at the lineage-specific genes, which are not expressed in stem cells. https://t.co/42oxepPouJ